Awarded contract
Pharmaceutical products
Details
- Supplier(s)
- Pfizer Liimted, Biogen Idec Ltd
- Value
- GBP 59,444,512
- Topic
- Pharmaceutical products
- Published
- 31 March 2016
- Source
- TedNotices
Tender description
This Framework Agreement is for the supply of Etanercept Subcutaneous Injections in 10mg, 25mg and 50mg strengths to NHS Scotland. Each product line was treated as an individual Lot and awarded on a line by line basis. Each Lot was awarded as an unranked multi supplier framework.
Timeline
- Completed: Award published31 March 2016Current notice
About the buyer
NHS National Services Scotland is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov |
6 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS National Services Scotland.
BuyersCountValue
- 19£4.6m
- 9£1.1m
- 7£505.5k
- 4£964.7k
- 2£252.0k
- 1£4.4m
- 762£1.9bn
- 231£2.0bn
- 138£1.4bn
- 135£63.9m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
